Current concepts in nonoperative management of knee osteoarthritis

Orthopedics

Volumn 28, Issue 2, 2005, Pages 134-139

  Wu, Susan S ^a,c   Tuan, Kenneth ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c Mt Vernon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; ALCOHOL; ANALGESIC AGENT; CAPSAICIN; CELECOXIB; CHONDROITIN SULFATE; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; GLUCOSAMINE; HYALURONIC ACID; IBUPROFEN; INDOMETACIN; INTERLEUKIN 1BETA; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PLACEBO; PROTEOGLYCAN; ROFECOXIB; SALICYLATE SODIUM; SALICYLIC ACID DERIVATIVE; UNINDEXED DRUG; VALDECOXIB;

ACUPUNCTURE ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; BRACE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSERVATIVE TREATMENT; DISEASE COURSE; DOSE RESPONSE; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG COST; DRUG HALF LIFE; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EDUCATION PROGRAM; ENZYME INHIBITION; EXERCISE; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HUMAN; HYPERTENSION; INFLAMMATION; INJECTION SITE REACTION; JOINT DEGENERATION; JOINT INJURY; KIDNEY DISEASE; KIDNEY FAILURE; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MONOTHERAPY; OBESITY; OPTIMAL DRUG DOSE; PATIENT EDUCATION; PHYSICAL DISABILITY; PROPRIOCEPTION; PROTEIN SYNTHESIS INHIBITION; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; VALGUS KNEE; WEIGHT BEARING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 14544285559     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/0147-7447-20050201-14     Document Type: Article

References (54)

1. Berman BM, Singh BB, Lao L, et al. A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee. Rheumatology (Oxford). 1999; 38:346-354.
2. Buckwalter JA, Lappin DR. The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop. 2000; 372:159-168.
3. Felson DT. Epidemiology of OA. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Oxford, England: Oxford University Press; 1998:12-22.
4. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000; 43:1905-1915.
5. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum. 1993; 36:439-446.
6. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment. Arthritis Care Res. 1996; 9:292-301.
7. Weinberger M, Tierney WM, Cowper PA, et al. Cost-effectiveness of increased telephone contact for patients with osteoarthritis. A randomized, controlled trial. Arthritis Rheum. 1993; 36:243-246.
8. Cooper C, Dennison E. The natural history and diagnosis of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Oxford, England: Oxford University Press; 1998:237-249.
9. Spector TD, Dacre JE, Harris PA, et al. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis. 1992; 51:1107-1110.
10. Cooper CR. Osteoarthritis and related disorders. In: Klippel JH, Dieppe PA, eds. Rheumatology. London, England: Mosby; 1998:8:2.1-8:2.8.
11. Topp R, Woolley S, Hornyak J III, et al. The effect of dynamic versus isometric resistance training on pain and functioning among adults with osteoarthritis of the knee. Arch Phys Med Rehabil. 2002; 83:1187-1195.
12. Ettinger WH Jr, Burns R, Messier SP, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA. 1997; 277:25-31.
13. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med. 1992; 116:535-539.
14. Ahlback S. Osteoarthrosis of the knee. A radiographic investigation. Acta Radiol Diagn (Stockh). 1968; 277(suppl):7-72.
15. Prodromos CC, Andriacchi TP, Galante JO. A relationship between gait and clinical changes following high tibial osteotomy. J Bone Joint Surg Am. 1985; 67:1188-1194.
16. Hewett TE, Noyes FR, Barber-Westin SD, et al. Decrease in knee joint pain and increase in function in patients with medial compartment arthrosis: a prospective analysis of valgus bracing. Orthopedics. 1998; 21:131-138.
17. Matsuno H, Kadowaki KM, Tsuji H. Generation II knee bracing for severe medial compartment osteoarthritis of the knee. Arch Phys Med Rehabil. 1997; 78:745-749.
18. Pollo FE, Otis JC, Backus SI, et al. Reduction of medial compartment loads with valgus bracing of the osteoarthritic knee. Am J Sports Med. 2002; 30:414-421.
19. Kerrigan DC, Todd MK, Riley PO. Knee osteoarthritis and high-heeled shoes. Lancet. 1998; 351:1399-1401.
20. Kerrigan DC, Lelas JL, Karvosky ME. Women's shoes and knee osteoarthritis. Lancet. 2001; 357:1097-1098.
21. Yasuda K, Sasaki T. The mechanics of treatment of the osteoarthritic knee with a wedged insole. Clin Orthop. 1987; 215:162-172.
22. Wolfe SA, Brueckmann FR. Conservative treatment of genu valgus and varum with medial/lateral heel wedges. Indiana Med. 1991; 84:614-615.
23. Keating EM, Faris PM, Ritter MA, et al. Use of lateral heel and sole wedges in the treatment of medial osteoarthritis of the knee. Orthop Rev. 1993; 22:921-924.
24. Crenshaw SJ, Pollo FE, Calton EF. Effects of lateral-wedged insoles on kinetics at the knee. Clin Orthop. 2000; 375:185-192.
25. Kerrigan DC, Lelas JL, Goggins J, et al. Effectiveness of a lateral-wedge insole on knee varus torque in patients with knee osteoarthritis. Arch Phys Med Rehabil. 2002; 83:889-893.
26. Hylek EM, Heiman H, Skates SJ, et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998; 279:657-662.
27. Altman RD, IAP Study Group. Ibuprofen, acetaminophen, and placebo in osteoarthritis of the knee: a 6 day double-blind study [abstract]. Arthritis Rheum. 1999; 42(suppl 9):S403.
28. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ. 1998; 317:526-530
29. Garell S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of NSAID agents. Medicine (Baltimore). 1984; 63:165-181.
30. Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation. 2002; 26:139-142.
31. Lipsky PK. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop. 1999; 28(suppl 3):8-12.
32. Lane JM. Anti-inflammatory medications: selective COX-2 inhibitors. J Am Acad Orthop Surg. 2002; 10:75-78.
33. Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ. 2002; 325:619-623.
34. Geba GP, Weaver AL, Polis AB, Schnitzer TJ; Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. 2002; 287:64-71.
35. Hawkey C, Kahan A, Steinbruck K, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-Scale International Study Safety Assessment. Br J Rheumatol. 1998; 37:937-945.
36. Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Rosko P. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators. Arch Intern Med. 2000; 160:2947-2954.
37. Moore RA, Tramer MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998; 316:333-338.
38. Rovensky J, Micekova D, Gubzova Z, et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Exp Clin Res. 2001; 27:209-221.
39. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage. 1998; 6(suppl A):37-38.
40. Kato Y, Mukudai Y, Okimura A, et al. Effects of hyaluronic acid on the release of cartilage matrix proteoglycan and fibronectin from the cell matrix layer of chondrocyte cultures: interactions between hyaluronic acid and chondroitin sulfate glycosaminoglycan. J Rheumatol Suppl. 1995; 43:158-159.
41. Leeb BF, Schweitzer H, Montag K, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol. 2000; 205-211.
42. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. 1999; 25:379-395.
43. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001; 357:251-256.
44. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002; 162:2113-2123.
45. Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis. 1997; 56:634-636.
46. Ravaud P, Moulinier L, Giraudeau B, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 1999; 42:475-482.
47. Marshall KW, Waddell DD. Non-operative management of osteoarthritis of the knee. In: DiNubile NA, ed. The Physician and Sports Medicine. A Special Report - Osteoarthritis of the Knee: Keeping Aging Athletes Active. New York, NY: McGraw Hill Healthcare Information Programs; 2000:14-19.
48. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002; 162:292-298.
49. Marshall KW. Viscosupplementation for osteoarthritis: current status, unresolved issues, and future directions. J Rheumatol. 1998; 25:2056-2058.
50. Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician. 2000; 62:565-570, 572.
51. Hochberg MC. Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthritis Rheum. 2000; 30(2 suppl1):2-10.
52. Leopold SS, Redd BB, Warme WJ, et al. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. J Bone Joint Surg Am. 2003; 85:1197-1203.
53. Paramore LC. Use of alternate therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey. J Pain Symptom Manage. 1997; 13:83-89.
54. Ezzo J, Hadhazy V, Birch S, et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2001; 44:819-825.